Skip to main content

#160933

RLUN001-2 Lung cancer organoid

Cat. #160933

RLUN001-2 Lung cancer organoid

Cat. #: 160933

Sub-type: Organoids

Unit size: 40-100 uL of cell pellet/vial, 1ml

Availability: 8-10 weeks

Organism: Human

Tissue: Lung

£2,500.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Medical-Industrial Translational Research Center

Institute: Fukushima Medical University

Primary Citation: Takahashi et al. 2019. Cells 20: 481. PMC6562414

Tool Details
Handling
Application Details
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: RLUN001-2 Lung cancer organoid
  • Alternate name: RLUN001-2, RLUN1-2, RLUN1, RLUN001
  • Cancer: Lung cancer
  • Cancers detailed: Lung;Papillary adenocarcinoma
  • Age y o : 67
  • Research fields: Cancer
  • Tool sub type: Organoids
  • Organism: Human
  • Tissue: Lung
  • Gender: Female
  • Growth properties: Suspension
  • Application: 3D cell culture
  • Description: A series of novel patient-derived organoids (PDOs) have been constructed from different tumor tissue types under the Fukushima Translational Research Project, designated as F-PDO. F-PDOs form large cell clusters with a morphology similar to the original tumor and can be cultured for more than six months. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of F-PDOs were similar to their source tumors, even after long-term growth in culture conditions
  • Biosafety level: 2

Handling

  • Format: Frozen
  • Passage number: 5
  • Growth medium: Cancer Cell Expansion Media plus (Fujifilm Wako Pure Chemical, Ltd.).
  • Temperature: 37°
  • Atmosphere: 5% CO2
  • Volume: 1 ml
  • Storage medium: CELLBANKER 2
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Pathogen and stelility test; Comprehensive gene expression analysis; Cancer panel sequencing; Whole exome sequencing
  • Mycoplasma free: Yes
  • Biosafety level: 2

Application Details

  • Application: 3D cell culture

References

  • Takahashi et al. 2019. Cells 20: 481. PMC6562414

Documentation

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.